The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Bayer; Janssen
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Speakers' Bureau - Bayer
Research Funding - Bayer
A randomized, phase II study of repeated rhenium-188-HEDP (rhenium) combined with docetaxel versus docetaxel alone in castration resistant prostate cancer (CRPC) metastatic to bone: The Taxium II trial.
 
Joyce M. van Dodewaard-de Jong
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Novartis
 
Haiko Bloemendal
Research Funding - Sanofi (Inst)
 
John M. H. de Klerk
No Relationships to Disclose
 
Daniela E Oprea-Lager
No Relationships to Disclose
 
Otto S. Hoekstra
No Relationships to Disclose
 
H Pieter van den Berg
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck
Speakers' Bureau - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Sanofi
 
Maartje Los
No Relationships to Disclose
 
Aart Beeker
No Relationships to Disclose
 
Joe M. O'Sullivan
No Relationships to Disclose
 
Henk M.W. Verheul
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim (Inst)
Research Funding - Amgen (Inst); Immunovo (Inst); Roche/Genentech (Inst); Vitromics (Inst)
 
Alfonsus Johannes Maria van den Eertwegh
Honoraria - Astellas Pharma; Bayer
Consulting or Advisory Role - Astellas Pharma
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma